AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study NCT06757374 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: EXPERIMENTAL
Intervention: Resistin
Description: Considering the HG effect on endocrinologic and metabolic complications, resistin levels in maternal serum may change in the presence of HG severity
Study NCT06512051 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: SHR-A2102；Adebrelimab；Cisplatin/ Carboplatin
Description: Drug: SHR-A2102~Drug: Adebrelimab~Drug: Cisplatin/ Carboplatin
Study NCT04280523 — intervention group
Intervention type: DRUG
Intervention: ESR-specific PET scan
Description: Lung ESR Density by PET: Investigators will use 18F-FES as an estrogen receptor (ESR)-specific PET tracer to determine lung ESR density. 18F-FES will be prepared according to published methods. Briefly, all subjects will be evaluated by PET imaging, using standardized protocols. Blood will be obtained just before FES injection to measure the endogenous estrogen level \[estradiol (E2)\], to rule out pregnancy in female patients, and some reserved for future studies of mechanism. Approximately 6 mCi (222 MBq) of 18F-FES will be administered intravenously over 1\~2 minutes, with scanning initiated 1 hour after administration of the tracer. Emission scans will be performed of the chest. A multimodality computer platform (Syngo; Siemens) will be used for image review and manipulation.
Study NCT06534918 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Nutrition Course
Description: The virtual, synchronous nutrition course will be a 30-60 minute group education class on nutrition information for cancer survivors. The class will be held once per week.
Study NCT06534918 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Physical Activity Program
Description: The Physical Activity Program will be held virtually or in-person. This will be a 1-hour biweekly group education class on aerobic and resistance exercise recommendations for cancer survivors.
Study NCT06534918 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Weekly One on One Session with Registered Dietitian
Description: Participants will be referred to weekly one on one sessions with a Registered Dietitian. The one on one sessions are anticipated to last 30-60 minutes, based on the needs of the individual.
Study NCT06534918 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Weekly One on One Session with an Exercise Physiologist
Description: Participants will be referred to weekly one on one sessions with an Exercise Physiologist. The one on one sessions are anticipated to last 30-60 minutes, based on the needs of the individual
Study NCT06534918 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Nutrition Prescription
Description: The nutrition prescription pad serves as a quick checklist designed to assist participants in effectively monitoring their dietary habits. Participants randomized to intervention group will each receive a one-time nutrition prescription in person during their first intervention week.
Study NCT06534918 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Physical Activity Prescription
Description: The physical activity prescription pad serves as a quick checklist designed to assist participants in effectively monitoring their exercise routines. Participants randomized to intervention group will each receive a one-time physical prescription in person during their first intervention week.
Study NCT06306222 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Laser lithotripsy
Description: Ureteroscopic laser lithotripsy
Study NCT06306222 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Laser lithotripsy
Description: Ureteroscopic laser lithotripsy
Study NCT04768556 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: EEG experimental sessions 1
Description: An EEG experimentation session on the stop-signal task of inhibiting a prepared discrete graphic action.
Study NCT04768556 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: EEG experimental sessions 1
Description: An EEG experimentation session on the stop-signal task of inhibiting a prepared discrete graphic action.
Study NCT04768556 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: EEG experimental sessions 2
Description: An EEG experimentation session on the stop-signal task of inhibiting an ongoing rhythmic action
Study NCT04768556 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: EEG experimental sessions 2
Description: An EEG experimentation session on the stop-signal task of inhibiting an ongoing rhythmic action
Study NCT05082688 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Herpes zoster vaccination (Shingrix, GSK)
Description: Shingrix is an ASO1-adjuvanted herpes zoster vaccination used to prevent shingles and its associated complications in at-risk populations
Study NCT05082688 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Influenza Vaccine (Fluarix Tetra Northern Hemisphere 2021 or 2022, GSK)
Description: Fluarix Tetra is a quadrivalent inactivated influenza vaccine
Study NCT05082688 — intervention group
Intervention type: BIOLOGICAL
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: 0.9% NaCl
Study NCT05908227 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: NHF high
Description: Nasal high flow therapy 8L/min.
Study NCT05908227 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: NHF low
Description: Nasal high flow therapy 6L/min.
Study NCT05908227 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: NCPAP
Description: Nasal continuous positive airway pressure 6 cm H20
Study NCT05304897 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: PRP treatment
Description: PRP treatment for bronchopleural fistula
Study NCT05726097 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: polyethylene glycol
Description: colonic preparation
Study NCT06031441 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: RO7566802
Description: RO7566802 solution for infusion will be administered as specified in each treatment arm.
Study NCT06031441 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Atezolizumab
Description: Atezolizumab solution for infusion will be administered as specified in each treatment arm.
Study NCT05726097 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: sodium phosphate
Description: colonic preparation
Study NCT05726097 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: polyethylene glycol + ascorbic acid
Description: colonic preparation
Study NCT05726097 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: gastrografin
Description: colonic preparation
Study NCT05726097 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: magnesiumoxid + sodium picosulfate
Description: colonic preparation
Study NCT05726097 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: prucalopride
Description: colonic preparation
Study NCT06173622 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Fetal Positioning
Description: In the study, venipuncture was applied to the intervention and control groups. While the procedure was performed by an experienced neonatal nurse, the neonates' pain score, crying duration and physiological parameters were monitored by another researcher (observer).
Study NCT05967273 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: CirrhosisRx CDS
Description: CirrhosisRx is a cirrhosis-specific CDS that organizes clinical data into clinically relevant groupings and links them to order sets consistent with national practice guidelines for inpatient cirrhosis care.
Study NCT04852523 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: 18F-fluciclovine
Description: 18F-Fluciclovine is a synthetic L-leucine amino acid used clinically for PET imaging in patients with biochemical recurrence of prostate cancer following definitive therapy. The pancreas accumulates striking amounts of Axumin, where it is considered a normal finding. Pancreatic beta-cell function may be slow to recover following pancreatic transplantation and may vary as a function of perioperative steroid administration, acute rejection, inadequate islet cell transplantation, allograft pancreatitis or compromised blood supply. Viability of the allograft is a common clinical concern and is difficult to assess based on insulin, C-peptide, and blood sugar levels. Rapid identification of compromised allograft viability is critical in the management of these patients.
Study NCT05781932 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Dermal barb suture combined with medical glue
Description: In the experimental group, after tension reduction and suture were completed, the wound and surrounding skin were wiped clean with normal saline and clean gauze, and the blood accumulated in the wound was squeezed out. Histoacryl medical tissue glue (specification:0.5 ml/piece, main components: n-butyl 2-cyanoacrylate (embutate), pigment (1-hydroxy-4\[(toluene)amino\]-9,10-anthraquinone), and stabilizers (p-diphenol, sulfur dioxide, phosphoric acid)) were evenly spread on the surgical incision and kept in the butt state for 4 to 6 seconds. After it got solidify and dry, a sterile gauze covered the surgical incision. There was no need to disinfect and change the dressings after the operation. Patients can shower normally on the day after the operation by just avoiding rubbing the incision covered with glue. Patients can move normally 1-2 days after the operation, and the glue film falls off on its own within 5-10 days.
Study NCT05582226 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: ACL reconstruction
Description: Orthopedic surgical operation in which a ruptured anterior cruciate ligament is repaired and reattached to the muscle connection points with a graft, a fashioned ligament that is meant to serve as a replacement for the ruptured muscle tissue.
Study NCT05582226 — intervention group
Intervention type: PROCEDURE
Group type: OTHER
Intervention: ACL reconstruction
Description: Orthopedic surgical operation in which a ruptured anterior cruciate ligament is repaired and reattached to the muscle connection points with a graft, a fashioned ligament that is meant to serve as a replacement for the ruptured muscle tissue.
Study NCT05407857 — intervention group
Intervention type: BEHAVIORAL
Group type: PLACEBO_COMPARATOR
Intervention: multi-modal non-pharmacological intervention
Description: multi-modal non-pharmacological intervention including the management with nutrition, exercise and cognitive programs
Study NCT05407857 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: multi-modal non-pharmacological intervention
Description: multi-modal non-pharmacological intervention including the management with nutrition, exercise and cognitive programs
Study NCT05407857 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: multi-modal non-pharmacological intervention
Description: multi-modal non-pharmacological intervention including the management with nutrition, exercise and cognitive programs
Study NCT05392803 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Active then Sham Treatment
Description: Application of 30 days of nonthermal, pulsed shortwave (radiofrequency) therapy; then sham treatment after a 7-day washout period
Study NCT05392803 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Sham then Active Treatment
Description: Application of 30 days of sham treatment; then 30 days of nonthermal, pulsed shortwave (radiofrequency) therapy after a 7-day washout period
Study NCT04894890 — intervention group
Intervention type: DRUG
Intervention: secukinumab
Description: There is no treatment allocation. Patients administered secukinumab by prescription that have started before inclusion of the patient into the study will be enrolled.
Study NCT06485388 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Propofol
Description: Venous blood samples will be taken from the patients included in the study and incubated with propofol (dose: 100, 250, 500 and 1000µM) after appropriate procedures in the laboratory environment. . After incubation, all resuspensions will be subjected to flow cytometric analysis to evaluate erythrocyte NO synthase activity and erythrocyte-mediated NO release.
Study NCT06485388 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Thiopental
Description: Venous blood samples will be taken from the patients included in the study and incubated with thiopental (dose: 100, 250, 500 and 1000µM) after appropriate procedures in the laboratory environment. . After incubation, all resuspensions will be subjected to flow cytometric analysis to evaluate erythrocyte NO synthase activity and erythrocyte-mediated NO release.
Study NCT06006403 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: CD123 targeted CAR-NK cells
Description: Administration method: intravenous infusion； Subjects will receive conditioning therapy by Fludarabine and Cyclophosphamide before cell infusion.
Study NCT05582226 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Mesenchymal stem cell implantation
Description: Stem cells are to be extracted from tissue at the stump of the ACL attachment point and inserted on the graft in the hopes of improving healing response
Study NCT05701527 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: EBC-129
Description: EBC-129 will be administered on Day 1 of each 21-Day cycle (Parts A, B, and C), and Day 1 of each 21- or 28-Day cycle (Part D) via a 30-120-minute intravenous (IV) fusion.
Study NCT05907070 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Mandala group
Description: Mandala group will participate in 2 sessions of individual mandala drawing art activity with the theme of 'Emotions' accompanied by classical or instrumental music. In each session, a mandala will be created.
Study NCT05549180 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: BIKTARVY 50Mg-200Mg-25Mg Tablet and Dovato placebo
Description: The patients randomized to experimental arm will be randomized to Biktarvy + Dovato placebo
Study NCT05907070 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Value clarification group
Description: Value clarification groups will participate in the value clarification activity by writing 2 sessions individually with the theme of 'Emotions' accompanied by classical or instrumental music.
Study NCT05549180 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Dovato 50Mg-300Mg Tablet + Biktarvy placebo
Description: The patients randomized to comparador arm will be randomized to Dovato + Biktarvy placebo
Study NCT06582173 — intervention group
Intervention type: OTHER
Intervention: Face-to-face interviews assisted by a biographical grid
Description: Face-to-face interviews assisted by a biographical grid.~Healthcare event of the adolescent :~* medical specialist appointment~* general practitioner appointment~* emergency services use~* hospital admission~* diagnostic test~* medication use~* non-pharmacological treatment~* nursing or physical therapy~* alternative care~Biographical of the adolescent :~* Education event~  * Class/level~ * School~ * Attendance~ * Special arrangements~ * Grades~ * Off school education~* Family event~  * Separation/union~ * Birth/death~ * Leave/Arrival~ * Location/Moving~ * Disease/accident~* Peer events~  * Friendships~ * Love interests~ * Bullying~* Leisure \& interests events~  * Activity~ * Frequency
Study NCT06581718 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Eye Gaze Control
Description: Eye Gaze Control - UGI and LGI endoscopy
Study NCT06332014 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Prolia
Description: Partcipants will receive subcutaneous (SC) injections of Prolia Q6M.
Study NCT06233422 — intervention group
Intervention type: OTHER
Intervention: No intervention involved
Description: No intervention involved
Study NCT04500665 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Colchicine
Description: Colchicine
Study NCT04500665 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Placebo
Study NCT05701527 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Pembrolizumab
Description: Pembrolizumab will be administered at the dose of 200 mg IV every 21 days.
Study NCT05494034 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Reveal LINQTM
Description: implantable cardiac monitoring device (Reveal LINQTM)
Study NCT00808197 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: ocular blood flow measurement
Description: Ocular blood flow will be determined by non-invasive methods, including laser Doppler flowmetry and laser interferometry
Study NCT04008160 — intervention group
Intervention type: DEVICE
Intervention: ProTex
Description: Non invasive measurement of pressure, temperature, humidity, perfusion, and oxygenation
Study NCT04923009 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: ICE visualization and map construction
Description: Radio-frequency ablation of atrial fibrillation
Study NCT04923009 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: ICE visualization and map construction
Description: Radio-frequency ablation of atrial fibrillation
Study NCT05199389 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Multiwave Locked System® (M6 laser, ASA srl, Arcugnano (VI), Italy)
Description: MLS® Laser M6 is a PBM device that allows the patients to be treated in various positions, either sitting, lying down or at a distance, without risk of contamination. Treatment times are carefully calibrated to deliver the best possible energy dose to the tissue being treated.
Study NCT05500911 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: sinus lift
Description: when residual bone height is >4 mm sinus lift through crestal approach procedure will be performed and after sinus flor elevation, OSSIX® Bone will be placed in the sinus cavity.
Study NCT05500911 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: implant placement
Description: Implant will be placed in edentulous area
Study NCT04983849 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: metronidazole hydrogel
Description: scaling and root planning in adjunct to the use of metronidazole in the periodontal pocket
Study NCT04983849 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: scaling and root planning
Description: scaling and root planning
Study NCT04866147 — intervention group
Intervention type: PROCEDURE
Intervention: Cardiothoracic surgery
Description: Cardiac \& large intrathoracic vessels, respiratory, thoracic, mediastinal \& diaphragmatic procedures
Study NCT04866147 — intervention group
Intervention type: PROCEDURE
Intervention: Breast surgery
Description: Breast resections \& mastectomies
Study NCT04866147 — intervention group
Intervention type: PROCEDURE
Intervention: Gastrointestinal surgery
Description: Digestive \& spleen
Study NCT04866147 — intervention group
Intervention type: PROCEDURE
Intervention: Genitourinary surgery
Description: Urinary tract, genital \& retroperitoneal tissue
Study NCT04866147 — intervention group
Intervention type: PROCEDURE
Intervention: Orthopaedic surgery
Description: Back \& neck, shoulder \& upper arm, hip \& thigh, knees \& lower leg
Study NCT02546102 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: ICT-107
Description: Autologous dendritic cells pulsed with peptides associated with tumor antigens
Study NCT02546102 — intervention group
Intervention type: BIOLOGICAL
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Control, autologous monocytes-enriched PBMC.
Study NCT06005844 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: OTHER
Intervention: Cerebellar Cognitive-Affective Syndrome Scale
Description: The CCASS will be administered by a neuropsychologist starting with version 1A. An alternative version (1B, 1C or 1D) will also be administered. An interval of approximately 30 minutes should be observed between the two administrations. In order to assess the inter-rater reliability of the scale, a second neuropsychologist will be present in the room and will independently evaluate (i.e., blind to his/her colleague's rating) patient's responses. The choice of alternative version (i.e., 1B, 1C, or 1D) will be randomized.
Study NCT04698200 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Cold exposure
Description: Whole body resting cold (+10 degrees centigrade) and heat (+40 degrees centigrade) for 60 minutes.
Study NCT05746832 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Endoscopic stenting Retrograde Cholangiopancreatography (ERCP)
Description: Assessment of the differences in stone size and the largest CBD diameter before and after stenting in one or two sessions. Stone clearance and complications were also determined with the ERCP, and factors associated with complete clearance were evaluated in patients with difficult CBD stones (a large \[≥ 20 mm\] or multiple \[≥ 3 sized ≥ 15 mm\] CBD stones). And also compared the outcomes with conventional procedure of open surgery.
Study NCT06182839 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Canagliflozin 300Mg Tab
Description: Patients will get 1 pill of Canagliflozin 300 mg daily for one year.
Study NCT06182839 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Patients will get 1 pill of placebo daily for one year.
Study NCT05476965 — intervention group
Intervention type: COMBINATION_PRODUCT
Group type: EXPERIMENTAL
Intervention: induction therapy; surgery; radiotherapy
Description: Radiotherapy: de-escalation radiotherapy or standard radiotherapy
Study NCT05476965 — intervention group
Intervention type: COMBINATION_PRODUCT
Group type: ACTIVE_COMPARATOR
Intervention: induction therapy; surgery; radiotherapy
Description: Radiotherapy: de-escalation radiotherapy or standard radiotherapy
Study NCT04819997 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Educational Intervention
Description: Participate in videoconference session
Study NCT05856019 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: J Stroke Myofascial Release
Description: Group A will receive J stroke myofascial release on planter fascia (with hot pack for 10-15 minutes on calf) 3 sessions per week for 4 weeks.